GlassScriptPhysician profile
Alberto Fernandez
NPI 1467452193
$5,125.94
in general payments reported to CMS, 2019-2025
22 companies · $1,675 in 2025
The $1,675 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $216 · 2021: $344 · 2022: $377 · 2023: $992 · 2024: $902 · 2025: $1,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,568.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,088.99 | 2019-2025 | |
| Glaxosmithkline, LLC. | $671.89 | 2021-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $623.81 | 2020-2025 | Dupixent |
| Optinose US, INC. | $587.72 | 2019-2025 | |
| Aerin Medical INC. | $499.92 | 2023-2025 | |
| Medtronic, INC. | $496.98 | 2024-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Inspire Medical Systems, INC. | $241.04 | 2024-2025 | Inspire |
| Medtronic USA, INC. | $167.30 | 2019 | |
| Acclarent, INC | $165.84 | 2021-2023 | Relieva Spinplus |
| Hikma Pharmaceuticals USA | $131.27 | 2023-2025 | Ryaltris |
| Abbott Laboratories | $121.88 | 2019 | |
| Intersect Ent, INC. | $66.05 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $41.52 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $38.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $34.98 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $33.73 | 2019-2022 | |
| Stryker Corporation | $31.90 | 2023 | |
| Alk-Abello, INC | $19.51 | 2021 | |
| Checkpoint Surgical, INC | $19.01 | 2023 | Checkpoint Stimulators |
| Aroa Biosurgery Incorporated | $16.32 | 2024 | |
| Cook Medical LLC | $14.15 | 2025 | Rosen |
| Smith+Nephew, INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.